Skip to main content
. 2022 Dec 1;41(4):859–870. doi: 10.1200/JCO.22.01342

TABLE 3.

Benefits and Harms of Risk-Reducing Medication (Tamoxifen), Screening Mammography, and Supplemental Screening With Magnetic Resonance Imaging in 35-, 50-, and 65-Year-Old Women on the Basis of History of Breast Biopsy and Family History of Breast Cancer

graphic file with name jco-41-859-g003.jpg